Merit Medical Systems, Inc. (MMSI) PT Raised to $97 at BofA Securities

BofA Securities analyst Travis Steed raised the price target on Merit Medical Systems, Inc. (NASDAQ: MMSI) to $97.00 (from $92.00) while maintaining a Neutral rating.

The analyst comments "We hosted MMSI CFO Raul Parra today for a virtual fireside chat at the BofA SMID Cap Conference. We think MMSI sounded confident on the growth/margin outlook in 2026 and beyond (we wrote the 2H26 guidance looked beatable in our note: Q2 beat even extariff refund). The next key catalyst will be the LRP which MMSI says could come ~Q4 or before (MMSI planning timing/metrics). Full takeaways are below/inside. We raise our PO to $97 (from $92) which is now based on 21x our 2027E EPS (vs 20x prior) to reflect the upside we see in estimates and higher peer multiples. We reiterate our Neutral rating as MMSI’s current multiple leaves less room for stock appreciation vs peers."

You May Also Be Interested In

• Fiserv (FISV) PT Lowered to $60 at Freedom Broker
• Jefferies on Five Below (FIVE): 'Our latest channel checks reinforce our view that FIVE's momentum extends well beyond viral Squish trends'
• Berkshire adds significantly to Alphabet position, starts small position in DR Horton